The ISTH-BAT score and outcomes after endometrial ablation in women with heavy menstrual bleeding.
bleeding disorders
endometrial ablation techniques
heavy menstrual bleeding
Journal
Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
11
09
2023
received:
15
05
2023
accepted:
12
09
2023
medline:
14
11
2023
pubmed:
28
9
2023
entrez:
27
9
2023
Statut:
ppublish
Résumé
The International Society on Thrombosis and Haemostasis bleeding assessment tool (ISTH-BAT), is used during the diagnostic workup of bleeding disorders. Data on ISTH-BAT scores in women with heavy menstrual bleeding (HMB) undergoing endometrial ablation (EA) could be essential in optimizing HMB counselling. To investigate the postsurgical incidence of amenorrhea, dysmenorrhea, quality of life, re-intervention after EA, and ISTH-BAT score. This study included women who have undergone EA because of HMB. During a follow-up of 2 to 5 years, ISTH-BAT, pictorial blood assessment chart (PBAC), and Short Form-36 survey (SF-36) were administered. At 10 years of follow-up surgical re-interventions were evaluated. Seventy-one women were included of whom 77% (n = 55) had an ISTH-BAT score < 6, versus 23% (n = 16) ISTH-BAT score ≥6 (mean age 46.3 versus 42.3, p = 0.004). In the ISTH-BAT ≥6 group versus < 6 group, amenorrhea occurred in 63% (10/16) versus 82% (45/55) (p = 0.111), dysmenorrhea in 38% (6/16) versus 18% (10/55) (p = 0.111), and surgical re-intervention in 19% (3/16) versus 25% (14/55) (p = 0.582). SF-36 item (Bodily) pain was lower in the ISTH-BAT ≥6 group versus < 6 (median score 58.7 vs. 80.0, p = 0.104). An ISTH-BAT score ≥6 may be related to a lower amenorrhea incidence and higher dysmenorrhea rate after EA.
Sections du résumé
BACKGROUND
BACKGROUND
The International Society on Thrombosis and Haemostasis bleeding assessment tool (ISTH-BAT), is used during the diagnostic workup of bleeding disorders. Data on ISTH-BAT scores in women with heavy menstrual bleeding (HMB) undergoing endometrial ablation (EA) could be essential in optimizing HMB counselling.
OBJECTIVE
OBJECTIVE
To investigate the postsurgical incidence of amenorrhea, dysmenorrhea, quality of life, re-intervention after EA, and ISTH-BAT score.
METHODS
METHODS
This study included women who have undergone EA because of HMB. During a follow-up of 2 to 5 years, ISTH-BAT, pictorial blood assessment chart (PBAC), and Short Form-36 survey (SF-36) were administered. At 10 years of follow-up surgical re-interventions were evaluated.
RESULTS
RESULTS
Seventy-one women were included of whom 77% (n = 55) had an ISTH-BAT score < 6, versus 23% (n = 16) ISTH-BAT score ≥6 (mean age 46.3 versus 42.3, p = 0.004). In the ISTH-BAT ≥6 group versus < 6 group, amenorrhea occurred in 63% (10/16) versus 82% (45/55) (p = 0.111), dysmenorrhea in 38% (6/16) versus 18% (10/55) (p = 0.111), and surgical re-intervention in 19% (3/16) versus 25% (14/55) (p = 0.582). SF-36 item (Bodily) pain was lower in the ISTH-BAT ≥6 group versus < 6 (median score 58.7 vs. 80.0, p = 0.104).
CONCLUSIONS
CONCLUSIONS
An ISTH-BAT score ≥6 may be related to a lower amenorrhea incidence and higher dysmenorrhea rate after EA.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1573-1579Subventions
Organisme : No funding was received for this project.
Informations de copyright
© 2023 The Authors. Haemophilia published by John Wiley & Sons Ltd.
Références
Rae C, Furlong W, Horsman J, et al. Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life. Haemophilia. 2013;19:385-391. doi:10.1111/hae.12014
Knol HM, Bogchelman DH, Kluin-Nelemans HC, et al. Routine evaluation and treatment of unexplained menorrhagia: do we consider haemostatic disorders? Eur J Obstet Gynecol Reprod Biol. 2010;152:191-194. doi:10.1016/j.ejogrb.2010.05.026
James AH. Women and bleeding disorders. Haemophilia. 2010;16(5):160-167. doi:10.1111/j.1365-2516.2010.02315.x Suppl
Rodeghiero F, Tosetto A, Abshire T, et al. Perinatal/Pediatric Hemostasis Subcommittees Working G. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8:2063-2065. doi:10.1111/j.1538-7836.2010.03975.x
Biss TT, Blanchette VS, Clark DS, et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost. 2010;8:950-956. doi:10.1111/j.1538-7836.2010.03796.x
Halimeh S, Rott H, Kappert G. PBAC score: an easy-to-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding. Haemophilia. 2016;22:e217-220. doi:10.1111/hae.12886
Herman MC, Mak N, Geomini PM, Winkens B, Mol BW, Bongers MY. International Heavy Menstrual Bleeding IPDM-aCG. Is the Pictorial Blood Loss Assessment Chart (PBAC) score associated with treatment outcome after endometrial ablation for heavy menstrual bleeding? A cohort study. BJOG. 2017;124:277-282. doi:10.1111/1471-0528.14434
Beelen P, van der Velde M, Herman MC, et al. Treatment of women with heavy menstrual bleeding: results of a prospective cohort study alongside a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol. 2021;257:1-5. doi:10.1016/j.ejogrb.2020.11.071
Penninx JPM, Herman MC, Mol BW, Bongers MY. Five-year follow-up after comparing bipolar endometrial ablation with hydrothermablation for menorrhagia. Obstet Gynecol. 2011;118:1287-1292. doi:10.1097/AOG.0b013e318236f7ed
Rubin G, Wortman M, Kouides PA. Endometrial ablation for von Willebrand disease-related menorrhagia-experience with seven cases. Haemophilia. 2004;10:477-482. doi:10.1111/j.1365-2516.2004.00915.x
El-Nashar SA, Hopkins MR, Feitoza SS, et al. Global endometrial ablation for menorrhagia in women with bleeding disorders. Obstet Gynecol. 2007;109:1381-1387. doi:10.1097/01.AOG.0000265805.76453.33
Alesci SR, Schrumpf L, Krekeler S, Miesbach W. Gynecological surgery and obstetrical procedures in patients with bleeding disorders (von Willebrand Disease and carriers for haemophilia. Hamostaseologie. 2012;2012:A43.
Huq FY, Al-Haderi M, Kadir RA. The outcome of endometrial ablation in women with inherited bleeding disorders. Haemophilia. 2012;18:413-420. doi:10.1111/j.1365-2516.2011.02712.x
Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51:1055-1068. doi:10.1016/s0895-4356(98)00097-3
Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97:734-739. doi:10.1111/j.1471-0528.1990.tb16249.x
Huser M, Papikova Z, Dziakova M, Hudecek R, Ventruba P. Radiofrequency endometrial ablation-new possibility of heavy menstrual bleeding conservative treatment. Ceska Gynekol. 2018;83:418-423.
Munro MG, Critchley HOD, Fraser IS, Committee FMD. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143:393-408. doi:10.1002/ijgo.12666
Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006;332:749-755. doi:10.1136/bmj.38748.697465.55
Deligeoroglou E, Athanasopoulos N, Tsimaris P, Dimopoulos KD, Vrachnis N, Creatsas G. Evaluation and management of adolescent amenorrhea. Ann N Y Acad Sci. 2010;1205:23-32. doi:10.1111/j.1749-6632.2010.05669.x
Unsal A, Ayranci U, Tozun M, Arslan G, Calik E. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Ups J Med Sci. 2010;115:138-145. doi:10.3109/03009730903457218
Doherty D, Grabell J, Christopherson PA, et al. Zimmerman program i. variability in international society on thrombosis and haemostasis-scientific and standardization committee endorsed bleeding assessment tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance. J Thromb Haemost. 2023;21(4):880-886. doi:10.1016/j.jtha.2022.11.045.
Schulman S, Kearon C. Subcommittee on control of anticoagulation of the s, standardization committee of the international society on T, haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692-694. doi:10.1111/j.1538-7836.2005.01204.x
Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen. 2012;141:2-18. doi:10.1037/a0024338
Ragni MV, Machin N, Malec LM, et al. Von Willebrand factor for menorrhagia: a survey and literature review. Haemophilia. 2016;22:397-402. doi:10.1111/hae.12898
Lavin M, Aguila S, Dalton N, et al. Significant gynecological bleeding in women with low von Willebrand factor levels. Blood Adv. 2018;2:1784-1791. doi:10.1182/bloodadvances.2018017418
James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009;201:12 e1-8. doi:10.1016/j.ajog.2009.04.024
Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia. 1999;5:40-48. doi:10.1046/j.1365-2516.1999.00285.x
Care CoAH. Committee Opinion No.580: von Willebrand disease in women. Obstetrics Gynecology. 2013;122(6):1368-1373. doi:10.1097/01.AOG.0000438961.38979.19
Eising HP, Roest M, de Groot PG, et al. High prevalence of reduced thrombin generation and/or decreased platelet response in women with unexplained heavy menstrual bleeding. Int J Lab Hematol. 2018;40:268-275. doi:10.1111/ijlh.12775
Eising HP, Sanders YV, de Meris J, Leebeek FWG, Meijer K. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: a qualitative study in adult women with moderate or severe Von Willebrand disease. Haemophilia. 2018;24:950-956. doi:10.1111/hae.13552
Beelen P, van den Brink MJ, Herman MC, et al. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding. Am J Obstet Gynecol. 2021;224:187 e1-e10. doi:10.1016/j.ajog.2020.08.016
van den Brink MJ, Wiewel-Verschueren S, Beelen P, et al. Effect of lower VWF and FXI levels on levonorgestrel IUS and endometrial ablation treatment success in heavy menstrual bleeding: an exploratory study. Haemophilia. 2021;27:e756-e759. doi:10.1111/hae.14392
Beelen P, Reinders IMA, Scheepers WFW, et al. Prognostic factors for the failure of endometrial ablation: a systematic review and meta-analysis. Obstet Gynecol. 2019;134:1269-1281. doi:10.1097/AOG.0000000000003556
Wyatt SN, Banahan T, Tang Y, Nadendla K, Szychowski JM, Jenkins TR. Effect of radiofrequency endometrial ablation on dysmenorrhea. J Minim Invasive Gynecol. 2016;23:1163-1166. doi:10.1016/j.jmig.2016.08.825
Punt MC, Ruigrok ND, Bloemenkamp KWM, et al. Thrombocytopathy in the Netherlands Study G. Prevalence, burden and treatment effects of vaginal bleeding in women with (suspected) congenital platelet disorders throughout life: a cross-sectional study. Br J Haematol. 2022;196:215-223. doi:10.1111/bjh.17791
El-Nashar SA, Hopkins MR, Barnes SA, et al. Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders: a follow-up survey and systematic review. Am J Obstet Gynecol. 2010;202:348 e1-7. doi:10.1016/j.ajog.2009.11.032